Vicarious Surgical (NYSE:RBOT – Get Free Report) will issue its quarterly earnings data after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last posted its quarterly earnings results on Monday, March 4th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.05. During the same period in the previous year, the company earned ($0.16) EPS. On average, analysts expect Vicarious Surgical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Vicarious Surgical Price Performance
RBOT opened at $0.27 on Friday. Vicarious Surgical has a fifty-two week low of $0.20 and a fifty-two week high of $2.46. The business has a 50-day moving average of $0.33 and a 200-day moving average of $0.37. The company has a market capitalization of $47.45 million, a PE ratio of -0.55 and a beta of 1.18.
Analyst Ratings Changes
View Our Latest Research Report on RBOT
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Featured Articles
- Five stocks we like better than Vicarious Surgical
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MarketBeat Week in Review – 4/22 – 4/26
- Insider Trades May Not Tell You What You Think
- 3 Stocks Leading the U.S. Agriculture Comeback
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.